A new missense mutation in the CASR gene in familial interstitial lung disease with hypocalciuric hypercalcemia and defective granulocyte function.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

1. The extracellular calcium-sensing receptor regulates human fetal lung development via CFTR.Scientific reports · 2016
   Article
2. Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects.Clinical medicine insights. Circulatory, respiratory and pulmonary medicine · 2015
   Review
3. Interstitial lung diseases in children.Orphanet journal of rare diseases · 2010
   Review

Corrections and comments

• Comment on
  Gene expression profiling of familial and sporadic interstitial pneumonia.2007

Authors and funding

6 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as